Is a DAO Test Worth It? What a Low Result Actually Tells You
A 1,051-person study found 44% had DAO below the normal cutoff, with no link to histamine symptoms. A naturopathic doctor on how to read a low result.

Image by WJ_Y2017fufu via Pixabay
A DAO test can tell you something useful. On its own, it can't tell you whether you have histamine intolerance. If you've paid out of pocket for a serum DAO result and you're looking at a number under the reference range, the question that gets you somewhere isn't whether the number is low, but what else has to be true before that number means anything.
What DAO does
DAO is short for diamine oxidase. It is a copper-dependent enzyme, and its main job is to break histamine down inside your gut before that histamine can cross into your bloodstream. You produce it in the mature cells that line your small intestine, which are called enterocytes. Those cells sit at the tips of the villi, the small finger-like folds that do most of your absorbing.
Histamine intolerance is a clearance problem. The histamine is already there. Some of it arrives in food, some comes from your own cells, some is made by bacteria in your gut. You react because you're not clearing it fast enough for your own threshold, which is also why your tolerance can drop over time while your diet stays the same.
Histamine intolerance and MCAS aren't the same problem
Mast cell activation syndrome, or MCAS, is a release problem. The mast cells themselves are hypersensitive and trigger-happy. When they fire, they don't release histamine alone. Out comes tryptase, prostaglandins, leukotrienes, interleukins and a long list of other mediators.
The mechanisms differ in a way that changes what a DAO result can tell you. A DAO value is a measure of clearance and nothing else: not how readily your mast cells fire, and not what else they release when they do. People often ask a clearance measurement to answer a release question. If you want the line between the two conditions drawn more carefully, I went through it in the piece on what mast cells are doing in a reactive face.
What the newest review says about measuring it
A 2026 review in Biomolecules gathered what is currently known about DAO across gastrointestinal disease, and the authors give the measurement problem a section of its own.
Their central point is that circulating DAO in your blood shouldn't be read as a direct stand-in for DAO activity at the gut lining, where the enzyme does its work. Those are two different things. The blood test measures the more accessible one.
Several other problems stack up behind that. Assay methods haven't been standardized across labs. Reference intervals aren't well established. Values shift with circadian rhythm, across the menstrual cycle and during pregnancy. Studies have reported inconsistent relationships between serum DAO and how sick people feel.
There is a counterintuitive part as well. When the intestinal lining is badly damaged, serum DAO can rise rather than fall, seeing as the enzyme leaks out of injured cells and into the blood. A higher number isn't automatically a healthier gut. The authors conclude that serum DAO works as an adjunctive marker and can't be treated as a standalone diagnostic for histamine intolerance.
A low DAO result is more common than you'd guess
Two studies put numbers on this.
A Swedish population survey measured DAO in 1,051 adults drawn from the general public. 44% of them had DAO below the suggested normal cutoff. Very few reported reacting to histamine-rich foods, and the researchers found no association between DAO levels and reported symptoms. Age influenced the result in both sexes, and body mass index did too among the women. The authors concluded that the way DAO is measured needs to be re-evaluated, and that at current cutoff values it may not be usable as a tool for identifying histamine intolerance.
The second study is the mirror image. A German team performed placebo-controlled histamine challenges in 59 people suspected of having histamine intolerance. The condition was ruled out in 50 of them, which is 84.7%. Thirty-seven of them, which is 62.7%, reacted to the placebo. Serum DAO did trend lower in the small group who did appear to have it, though the values were so variable in everyone else that the authors judged the specificity insufficient for making the diagnosis.
The two studies together describe the problem well enough: low DAO is common in people with no symptoms, and symptoms are common in people whose challenge testing comes back negative. Neither finding rules the other in. That's roughly the position I took when a DAO-linked subtype of fibromyalgia came up last year.
What pushes DAO down
This is the part you can do something about, and I find it more useful than the number itself.
Because DAO is produced by the mature cells lining your intestine, anything that damages that lining tends to lower it. In celiac disease, DAO drops along with the flattening of the villi, then recovers partially on a gluten-free diet. Inflammatory bowel disease does something similar. So do chemotherapy and radiation injury to the gut, and so does malnutrition.
Medications can lower it too. The review lists verapamil, clavulanic acid, isoniazid, cefuroxime, metoclopramide, diclofenac and amitriptyline among them.
Alcohol does both jobs at once. It prompts histamine release, and it interferes with DAO breaking histamine back down.
Then there are the cofactors. The enzyme needs copper to function, and the authors recommend that vitamin B6, vitamin C and copper status all be assessed as part of a proper workup. Other amines in your food, putrescine and cadaverine, compete with histamine for the same enzyme. An overgrowth of histamine-producing bacteria adds to the load from the other side. Genetics contribute as well, through variants in the AOC1 gene that codes for the enzyme.
One caution covers this whole category. The same review notes that although various nutritional approaches have been proposed for supporting your own DAO production, the clinical evidence behind them is still limited, and better studies are needed before any of them can be recommended. I think the direction is right. The evidence isn't there yet, and I'd rather say so plainly.
Where a DAO supplement fits
This is the next question almost every time, so let me take it directly.
A DAO supplement is an enzyme you swallow with food, which means it works in the gut on the histamine in your meal. Its reach is limited to the gut, which is a narrower job than what mast cells are doing in MCAS. If mast cells are degranulating somewhere the swallowed enzyme never reaches, then the enzyme has little to act on, and histamine is only one of the mediators involved anyway.
The way I use it, when I use it, is as a phase-one tool. It is similar in spirit to giving someone pancreatic enzymes so the pancreas gets a break. It's also expensive, and by itself it doesn't change why your own production dropped in the first place. The 2026 review did not test supplementation at all, so nothing here should be read as evidence that it treats a condition. Whether it belongs in your plan is a question for the practitioner who can see your whole picture.
So is the test worth it?
It depends on what you plan to do with the result.
If a low DAO value comes back alongside a clear pattern of symptoms following food, a documented response to lowering histamine, and a workup that has excluded the other conditions producing the same complaints, then it adds something to the picture. If it's the only evidence you have, it can't carry that weight, and the two studies above are the reason. One lab value is a landmark, and a landmark only helps once you can see the rest of the map.
That's the same thing I say about MCAS criteria and about breath testing, and it isn't a counsel of despair so much as an argument for treating your own history as the primary document and the labs as supporting evidence. If you want the wider map of how these pieces connect, the MCAS resource hub collects it in one place.
None of this is medical advice, and it isn't a substitute for working with someone who knows your history. If you're living with MCAS and want a structured starting point, MCAS: What You Need to Know First walks through what the diagnosis actually means, where to begin, and what to do when diet alone isn't enough.
FAQ
Can you have histamine intolerance with a normal DAO level?
Yes. Serum DAO isn't a direct measure of the enzyme activity at your gut lining, which is where histamine from food is broken down. In the placebo-controlled challenge study, some people who did appear to have histamine intolerance had DAO values that overlapped with everyone else. A normal number doesn't rule the condition out.
Does a low DAO result mean I need a DAO supplement?
Not on its own. A low value is common in people with no histamine symptoms at all, so the result alone doesn't establish that histamine clearance is the source of your problem. The 2026 review didn't test supplementation. Whether a DAO supplement fits your situation is a decision to make with your own practitioner.
Is DAO testing the same as testing for MCAS?
No. DAO reflects how well histamine gets broken down, while mast cell activation syndrome involves mast cells releasing histamine along with tryptase, prostaglandins, leukotrienes and other mediators. A DAO result says nothing about how readily your mast cells fire. You're asking a different question with each workup.
Why do DAO results vary so much between labs?
The 2026 review points out that assay methods haven't been standardized and that reference intervals aren't well established. Values also shift with circadian rhythm, across the menstrual cycle and during pregnancy. Two results from two labs aren't always comparable.
What lowers DAO besides genetics?
Injury to the intestinal lining is the big one, since the enzyme is produced by the mature cells lining the small intestine. Celiac disease, inflammatory bowel disease, chemotherapy and radiation injury all reduce it. Alcohol, several common medications and low vitamin B6, vitamin C or copper status contribute as well.
References
- 1.
- 2.
- 3.




